Cigna (CI) Stock
Major US health insurer with pharmacy and care services. Here's the price, business snapshot, and what's worth knowing about Cigna in July 2026.
Cigna Corporation (CI) is a large, US‑based health‑care and services company combining traditional health insurance with pharmacy and care‑management services through its Evernorth business. Its revenue mix includes employer and individual medical plans, Medicare products, and pharmacy benefit management and care solutions. Investors typically watch member trends, medical cost inflation, price negotiations with providers and drug‑pricing dynamics — all of which can move margins and earnings. Cigna’s business is sensitive to regulation, reimbursement changes and economic cycles that affect employer-sponsored coverage. With a market capitalisation of about $82.08 billion, it’s considered a major industry participant, but not immune to competition from insurers, PBMs and new entrants. This summary is general educational information, not personalised financial advice. Investors should consider their own circumstances, risk tolerance and seek regulated advice if needed; values can fall as well as rise and past performance is not a guide to future results.
Why It’s Moving
Cigna Shares Surge on Fresh 'Outperform' Upgrade and Overwhelming Buy Consensus Ahead of 2026 Earnings
- Bernstein analyst Lance Wilkes upgraded the stock from 'Market Perform' to 'Outperform' with a price target of $358, signaling heightened confidence in Cigna's long-term growth despite recent market headwinds.
- A consensus of over a dozen analysts now holds a 'Strong Buy' or 'Buy' rating for the company, with average price targets exceeding $330, suggesting the market sees substantial upside potential from current trading levels.
- Earnings data for fiscal year 2026 is approaching, and analysts are highlighting that the company's current valuation does not reflect its strong operational performance and the optimistic outlook provided in recent guidance updates.
Cigna Shares Surge on Fresh 'Outperform' Upgrade and Overwhelming Buy Consensus Ahead of 2026 Earnings
- Bernstein analyst Lance Wilkes upgraded the stock from 'Market Perform' to 'Outperform' with a price target of $358, signaling heightened confidence in Cigna's long-term growth despite recent market headwinds.
- A consensus of over a dozen analysts now holds a 'Strong Buy' or 'Buy' rating for the company, with average price targets exceeding $330, suggesting the market sees substantial upside potential from current trading levels.
- Earnings data for fiscal year 2026 is approaching, and analysts are highlighting that the company's current valuation does not reflect its strong operational performance and the optimistic outlook provided in recent guidance updates.
When is the next earnings date for Cigna Corp (CI)?
The next earnings date for The Cigna Group (CI) is scheduled for July 30, 2026, before the market opens. This upcoming report will cover the second quarter (Q2) of fiscal year 2026. Historically, CI releases its quarterly results in late April, late July, late October, and late December. Investors should expect the official announcement and conference call to occur on this confirmed date.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Cigna's stock, believing it could rise to $324.34 from $279.12.
Financial Health
Cigna is showing strong performance with good profits, cash flow, and solid revenue growth.
Dividend
Cigna's dividend yield of 2.12% offers a moderate return for income-focused investors. If you invested $1000 you would be paid $21.20 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
CHEMED CORP
Provides hospice and palliative care services to patients facing life-limiting illness
ALIGNMENT HEALTHCARE INC
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
Brookdale
A leading owner and operator of senior living communities in the United States.
Baskets Featuring CI
The GLP-1 Insurance Gap Reshaping Weight Care in 2026
Cigna's decision to drop coverage for popular GLP-1 weight-loss drugs like Wegovy and Zepbound for its employees signals a potential shift in employer-sponsored healthcare. This policy change could drive significant demand toward affordable direct-to-consumer telehealth platforms and alternative digital weight management programs.
Published: 3 June 2026
Explore BasketMedicare Advantage Rate Hike Opportunities in 2026
The Centers for Medicare & Medicaid Services finalized a 2.48% payment increase for 2027, granting health insurers a surprise $13 billion funding boost. This collection features managed care organizations and healthcare providers poised to benefit from this highly favorable regulatory reversal.
Published: 10 April 2026
Explore BasketDefensive Equities | Risks in a Slowing Labour Market
After the U.S. economy unexpectedly shed 92,000 jobs in February, investors are seeking shelter from the resulting market volatility. This collection features resilient, non-cyclical companies that historically maintain their value and offer stability during periods of economic deceleration.
Published: 9 March 2026
Explore BasketUS Jobs Surge | Healthcare & Construction Stocks
The U.S. labor market showed surprising strength in January, adding far more jobs than anticipated, led by the healthcare and construction industries. This theme focuses on the companies benefiting from this robust and targeted hiring, signaling a potential expansion in these key sectors.
Published: 12 February 2026
Explore BasketMedicare Cost Stocks (UNH, CVS) May Benefit
The U.S. government's successful negotiation of lower prices for key Medicare drugs signals a major shift in pharmaceutical pricing power. This creates a potential investment opportunity in managed care and healthcare service companies poised to benefit from the system's increased focus on cost efficiency.
Published: 26 November 2025
Explore BasketHealthcare's Cybersecurity Imperative
The massive cyberattack on UnitedHealth's subsidiary has exposed critical vulnerabilities within the national healthcare system. This event is accelerating the demand for advanced cybersecurity solutions, creating a significant growth opportunity for firms that specialize in protecting sensitive medical data and infrastructure.
Published: 15 August 2025
Explore BasketFollowing Buffett's Healthcare Bet
Warren Buffett's Berkshire Hathaway is making a major $2.1 billion bet on UnitedHealth, signaling a strategic shift toward the healthcare sector. This theme focuses on other health insurers and healthcare providers that could benefit from this renewed investor confidence.
Published: 15 August 2025
Explore BasketHealthcare In The Crosshairs: Insurers Under Scrutiny
The Department of Justice is investigating UnitedHealth Group's Medicare billing, creating uncertainty for the nation's largest insurer. This situation presents a potential opportunity for rival health insurers to gain market share and for compliance-focused companies that help the industry navigate complex regulations.
Published: 25 July 2025
Explore BasketHealthcare Billing Integrity
This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.
Published: 11 July 2025
Explore BasketMedicaid Politics
Discover companies whose fortunes are closely tied to government healthcare funding decisions. These carefully selected stocks represent businesses with significant exposure to Medicaid, now facing heightened legislative uncertainty after Senator Tillis's retirement.
Published: 30 June 2025
Explore BasketEmployee Mental Health As A Benefit
Discover companies transforming workplace wellness through innovative mental health solutions. These carefully selected stocks represent businesses helping corporations attract and retain talent by offering digital therapy, virtual counseling, and wellness technologies as employee benefits.
Published: 17 June 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pharmacy & care growth
Evernorth’s pharmacy and care‑management services can drive revenue diversification and margin enhancement, though execution and pricing pressure matter.
US‑focused footprint
Cigna’s operations are primarily US‑centred, so domestic regulation and employer benefits trends heavily influence results; global shocks can still have indirect effects.
Regulation and margins
Policy shifts, reimbursement rates and drug pricing reforms can materially affect profitability — investors should factor regulatory risk into valuations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
